Ziekte van Parkinson:

Carroll C.B., Bain P.G., Teare L., Liu X., Joint C., Wroath C., Parkin S.G., Fox P., Wright D., Hobart J., Zajicek J.P. (2004). Cannabis for dyskinesia in Parkinson disease: a randomized double-blind crossover study. Neurology; 63(7):1245-50. 

Cannabis/ oraal

Venderova K., Ruzicka E., Vorisek V., Visnovsky P. (2004). Survey on cannabis use in Parkinson's disease: subjective improvement of motor symptoms. Movement Disorders;19(9):1102-6.

Cannabis/ oraal & inhalatie

Sieradzan K.A., Fox S.H., Hill M., Dick J.P., Crossman A.R., Brotchie J.M. (2001). Cannabinoids reduce levodopa-induced dyskinesia in Parkinson's disease: a pilot study.Neurology; 57(11):2108-2111.

Nabilone/ oraal

Sieradzan K.A., Fox S.H., Dick J., Brotchie J.M. (1998). The effects of the cannabinoid receptor agonist nabilone on L-DOPA induced dyskinesia in patients with idiopathic Parkinson's disease (PD). Movement Disorders;13(Suppl 2):29.

Nabilone/ oraal

Frankel J.P., Hughes A., Lees A.J., Stern G.M. (1990). Marijuana for parkinsonian tremor. Journal of Neurology, Neurosurgery and Psychiatry. May;53(5):436.

Cannabis/ inhalatie

Snider S.R., Consroe P. (1985). Beneficial and adverse effects of cannabidiol in a Parkinson patient with sinemet-induced dystonic dyskinesia. Neurology; 35(Suppl):201.

CBD/ oraal